Compare AROW & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AROW | CTKB |
|---|---|---|
| Founded | 1851 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 442.9M | 433.8M |
| IPO Year | N/A | 2021 |
| Metric | AROW | CTKB |
|---|---|---|
| Price | $30.00 | $5.64 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 4 |
| Target Price | ★ $28.00 | $5.88 |
| AVG Volume (30 Days) | 57.3K | ★ 1.9M |
| Earning Date | 10-30-2025 | 11-05-2025 |
| Dividend Yield | ★ 3.89% | N/A |
| EPS Growth | ★ 5.41 | N/A |
| EPS | ★ 2.07 | N/A |
| Revenue | $146,817,000.00 | ★ $196,828,000.00 |
| Revenue This Year | $25.16 | N/A |
| Revenue Next Year | $9.99 | $7.25 |
| P/E Ratio | $14.43 | ★ N/A |
| Revenue Growth | ★ 7.84 | N/A |
| 52 Week Low | $22.72 | $2.37 |
| 52 Week High | $33.56 | $7.30 |
| Indicator | AROW | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 52.49 | 66.53 |
| Support Level | $28.98 | $5.15 |
| Resistance Level | $30.96 | $5.95 |
| Average True Range (ATR) | 1.03 | 0.43 |
| MACD | -0.06 | 0.05 |
| Stochastic Oscillator | 36.70 | 66.15 |
Arrow Financial Corp is a holding company. It provides various advisory and administrative services and coordinates the general policies and operations of the banks. It provides financial products, including online and mobile banking, mortgages, commercial loans, investments, and others. The company also provides lending services including commercial and industrial lending to small and mid-sized companies; mortgage lending for residential and commercial properties; and consumer installment and home equity financing. The key source of company's revenue is interest income, fees, commission earned through its subsidiaries.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.